Ensysce Biosciences Inc.

NASDAQ: ENSC · Real-Time Price · USD
2.08
0.02 (0.97%)
At close: Aug 15, 2025, 3:59 PM
2.09
0.64%
After-hours: Aug 15, 2025, 05:36 PM EDT

Ensysce Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a 1.32M 1.3M 3.42M 181.8K 305.72K 515.03K 435.38K 490.47K 789.63K 1.43M 279.35K 207.47K 603.1K 1.64M 1.2M 444.52K 250.58K
Cost of Revenue
n/a n/a 3.8M 1.69M 947.23K 778.9K 2.23M 1.92M 1.64M 1.8M 6.44M 4.76M 5.31M 3.14M 2.19M 1.72M 463.22K 292.03K
Gross Profit
n/a 1.32M -2.5M 1.73M -765K -473K -1.72M -1.48M -1.15M -1.01M -5.01M -4.48M -5.1M -2.54M -553K -514K -18.7K -41.45K
Operating Income
-1.75M -1.97M -3.58M 644.75K -1.96M -1.84M -3.16M -2.71M -2.29M -2.56M -6.2M -6.16M -7.05M -4.8M -2.01M -16.89M -413K -524K
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 70.88K 1.12M n/a n/a n/a n/a n/a 229.00
Pretax Income
-1.73M -1.95M -3.56M 661.77K -1.97M -3.12M -3.5M -2.69M -2.24M -2.19M -5.48M -9.86M -7.92M -951K -10.04M -17.2M -958K -912K
Net Income
-1.73M -1.95M -3.56M 661.77K -1.97M -3.12M -3.5M -2.69M -2.23M -2.19M -5.49M -9.83M -8M -1.67M -10.04M -17.16M -936K -908K
Selling & General & Admin
1.2M 1.4M 1.08M 1.08M 1.19M 1.37M 1.44M 1.23M 1.14M 1.55M 1.19M 1.69M 1.95M 2.27M 1.45M 16.37M 393.91K 490.47K
Research & Development
1.92M 1.89M 3.8M 1.69M 947.23K 778.9K 2.23M 1.92M 1.64M 1.8M 6.44M 4.76M 5.31M 3.14M 2.19M 1.72M 463.22K 284.38K
Other Expenses
n/a -716 -865 -1.69M -947.23K -778.9K n/a -1.92M -490K -790K -1.43M -279K -207K -603K -1.64M -1.2M -445K -251K
Operating Expenses
3.12M 3.29M 4.88M 1.08M 1.19M 1.37M 3.67M 1.23M 1.14M 2.56M 1.19M 1.69M 1.95M 2.27M 1.45M 16.37M 393.91K 292.03K
Interest Expense
-3.16K 3.86K 10.75K 4.06K 27.56K 1.25M 344.8K 7.65K n/a 1.5K 51.86K 4.86K 37.78K 15.02K 1.43M 524.82K 910.33K 347.83K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
n/a 3.29M 4.88M 2.77M 2.14M 2.15M 3.67M 3.14M 2.29M 2.56M 7.63M 6.44M 7.26M 5.41M 3.64M 18.09M 857.13K 774.85K
Income Tax Expense
n/a n/a 74.00 n/a n/a -74 n/a n/a -3.33K n/a n/a n/a n/a -3.87M n/a n/a n/a n/a
Shares Outstanding (Basic)
2.2M 1.4M 1.23M 2M 2M 379.6K 2.26M 3.09M 2.27M 1.05M 534.51K 160.72K 141.6K 113.7K 100.37K 101.06K 66.89K 101.15K
Shares Outstanding (Diluted)
2.2M 1.4M 1.23M 659.36K 2M 379.63K 2.26M 3.09M 2.27M 1.05M 534.51K 160.73K 141.62K 113.7K 100.37K 101.07K 66.89K 101.15K
EPS (Basic)
-0.79 -1.39 -2.9 1.00 -0.98 -8.21 -1.55 -0.87 -0.98 -2.08 -18.24 -84.13 -62.35 -14.66 -108 -169.83 -13.99 -14.4
EPS (Diluted)
-0.79 -1.39 -2.9 1.00 -0.98 -8.21 -1.55 -0.87 -0.98 -2.08 -18.24 -84.13 -56.49 -14.66 -108 -169.8 -13.99 -13.76
EBITDA
-1.75M -1.94M -3.55M 665.83K -1.94M -1.87M -3.16M -2.68M -2.24M -2.19M -5.43M -9.85M -7.88M -936K -10.03M -17.18M -47.23K -564K
EBIT
n/a -1.94M -3.55M 665.83K -1.94M -1.87M -3.16M -2.68M -2.24M -2.19M -5.43M -9.85M -7.88M -936K -10.03M -17.18M -47.28K -524K
Depreciation & Amortization
n/a 1.97M -1.86M 21.08K -79 -112.08K n/a n/a 2.29M 2.56M 38.00 38.00 38.00 38.00 -151 50.00 50.00 51.00